Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

9 recalls · Class III, newest first

Class III · Low risk

Lamotrigine Tablets

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Terminated Particulate / foreign matter Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-247-97 D-1281-2020
Class III · Low risk

Tacrolimus Capsules

Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.

Terminated Particulate / foreign matter Mylan Pharmaceuticals Inc. NDC 0378-2047-01 D-1057-2020
Class III · Low risk

Sodium Chloride Ophthalmic Ointment USP

Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Terminated Particulate / foreign matter Akorn, Inc. NDC 17478-622-35 D-0859-2020

Recalls by year